Journal of Nutrition and Metabolism / 2012 / Article / Tab 1

Clinical Study

Flaxseed Lignan Complex Administration in Older Human Type 2 Diabetics Manages Central Obesity and Prothrombosis—An Invitation to Further Investigation into Polypharmacy Reduction

Table 1

Patient characteristics upon entry.

Parameter Value

Age (years)
Waist circumference (cm)
99.3 4.2
BMI (kg/m2) 31.2 2.2
Glucose (mMol/L) 7.1 0.8
A1c (%) 7.2 1.2
HDL-c (mMol/L) 1.1 0.1
LDL-c (mMol/L) 2.5 0.1
Small dense LDL-c (mMol/L)
0.3 0.04
Cholesterol (mMol/L)
4.6 0.3
Triglycerides (mMol/L)
1.7 0.2
BP: systolic (mm Hg)
137.4 5.1
BP: diastolic (mm Hg)
83.3 2.1
CRP (mG/L) 2.6 1.2
IL-6 (pG/mL) 3.7 1.9
TNF- (pG/mL) 1.2 0.2
Bleeding time (seconds)
219.2 11.6
Oxidised LDL (U/L) 56.8 4.6

Values reflect duplicate assays of each blood sample (volumes are for plasma). Values are rounded to the nearest tenth. Data (mean SEM) is for the 16 patients who completed the trial.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.